Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeits
about
Cefepime versus other beta-lactam antibiotics for the treatment of infections in non-neutropenic patientsAnti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactamsCefepime versus other beta-lactam antibiotics for the treatment of infections in non-neutropenic patientsAdditional anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patientsBeta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropeniaA therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation.Infection Probability Score, APACHE II and KARNOFSKY scoring systems as predictors of bloodstream infection onset in hematology-oncology patientsPrognostic factors influencing infection-related mortality in patients with acute leukemia in KoreaPrevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency MedicineAminoglycoside-free interventional antibiotic management in patients undergoing haemopoietic stem cell transplantation.Canadian clinical practice guidelines for invasive candidiasis in adults.Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneityTreatment of febrile neutropenia and prophylaxis in hematologic malignancies: a critical review and update.Evidence-based guidelines for empirical therapy of neutropenic fever in Korea.Phase II dose escalation study of caspofungin for invasive Aspergillosis.Pharmacological properties and clinical efficacy of a recently licensed systemic antifungal, caspofungin.Supportive therapy in medical therapy of head and neck tumors.Infectious complications in children with acute myeloid leukemia: decreased mortality in multicenter trial AML-BFM 2004.Neutropenic patients and their infectious complications at a University HospitalInfections during induction therapy of protocol CCLG-2008 in childhood acute lymphoblastic leukemia: a single-center experience with 256 cases in China.Current antimicrobial usage for the management of neutropenic fever in Korea: a nationwide surveyRapid reduction of central line infections in hospitalized pediatric oncology patients through simple quality improvement methodsConsiderations in the approach to invasive fungal infection in patients with haematological malignancies.Approach to fever assessment in ambulatory cancer patients receiving chemotherapy: a clinical practice guideline.Empiric vs. preemptive antifungal treatment: an appraisal of treatment strategies in haematological patients.Cost-effectiveness analysis comparing two approaches for empirical antifungal therapy in hematological patients with persistent febrile neutropenia.Use of inflammatory molecules to predict the occurrence of fever in onco-hematological patients with neutropenia.The Frequency, Antifungal Susceptibility and Enzymatic Profiles of Candida Species Isolated from Neutropenic Patients.Primary antifungal prophylaxis in acute myeloblastic leukemia and myelodysplastic syndrome--still an open question?Management of sepsis in neutropenic patients: guidelines from the infectious diseases working party of the German Society of Hematology and Oncology.Antifungal treatment strategies in patients with haematological diseases or cancer: from prophylaxis to empirical, pre-emptive and targeted therapy.The diagnostic utility of routine chest radiography in the evaluation of the initial fever in patients undergoing hematopoietic stem cell.Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).Diagnosis and management of gastrointestinal complications in adult cancer patients: evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors : guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and OncolAnti-infective prophylaxis in pediatric patients with acute myeloid leukemia.Our 2015 approach to invasive pulmonary aspergillosis.Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).Early Changes of Mannose-Binding Lectin, H-Ficolin, and Procalcitonin in Patients with Febrile Neutropenia: A Prospective Observational Study.Successful empirical antifungal therapy of intravenous itraconazole with pharmacokinetic evidence in pediatric cancer patients undergoing hematopoietic stem cell transplantation.
P2860
Q24200940-54EEF2C9-C444-4F59-AD09-7D9C31049DD8Q24236653-E858264F-A2AC-4CB6-86AD-03A39B9BEEF6Q24242482-60F3E592-C7C0-4C7B-A497-CD8AD62A3E17Q24246468-13611244-C124-4720-AD7E-6C7B49BA6246Q24248048-9FB03393-AD39-4D08-8473-53C90738CB0FQ33369834-10AC99B2-738F-4669-B4E7-9C3371FBBF34Q33588190-002FA70F-4835-493B-8663-1A3F08288444Q33599347-0281B70F-8131-4871-B90A-4C197F5B15D6Q33974292-77FD29BA-38E7-4BCD-B4C7-EF74EA992D64Q34180913-2DEEC48F-E4FA-41EE-B2E4-EEE4DD460DDBQ34237335-47272112-FD70-4F64-BC7B-6F4A621603BBQ34571008-0B30031A-54F8-4BDF-B781-429023F4DD27Q34667166-CFF3CC1E-EE5B-4986-92D4-0E2F5A54639FQ35033597-4D9AAD32-AAA2-42AD-BDC9-A30DD8D3E38BQ35598439-FF4170FB-FFB2-40CA-877F-2BF84534E011Q36176371-0A71A902-12A8-4D60-8F67-E93470CC12A2Q36529853-2A0E1366-479F-4779-B956-9D4B27BF1732Q36548058-2C26DB9F-F4D0-4F21-A7CF-6D306043A39AQ36753259-80E7BFB4-77FD-434B-819D-58BD2018052BQ36811650-7BA0066C-755E-4B14-8815-7C727A066B04Q37030218-A0184BA7-3B49-406A-A746-A79182B1FB5EQ37037648-6F55131F-BE4D-4413-806C-718FEA600B39Q37049537-1FD3A62F-0F7F-48E6-8254-4F6CD62BF113Q37152897-0CD90DF6-340D-4ACE-8059-2076EAC5C3A4Q37159577-0C18FD50-2041-4A6D-8E23-8B26A30BBD83Q37263911-FCA0D840-3397-4BE7-AB3C-C2FC32F7A049Q37371375-62096542-78BA-4CBC-ACC6-FD906029D44EQ37589021-CA728000-65B1-48FD-ABF7-8958DD3685BBQ37657464-79BCF815-0AB3-4C80-B0CA-7EA25C94A727Q37805910-F0341366-E82B-480D-B58A-E0176C985198Q37873552-947448FF-F3B0-4BAF-91B1-24ED787E48ECQ37914106-CB6555DE-D9D0-459D-A0E9-8E80306A0F48Q38013661-EBA6D02B-A1F2-49AA-9C8D-D097C9080C59Q38080794-5ADCB0B7-9D31-4744-B830-84F8BB74B293Q38081793-0F44CF1D-73C4-4179-9F05-7C5E95F9902CQ38264086-C59B5A03-7202-4EF8-8159-3FF41E2D5DC5Q38391049-739B66A6-A398-4C16-AF7D-F6FF836D99BBQ40041299-347DD559-0519-436E-B2F9-42872E390BF2Q40138990-2C7B980D-F887-4807-910B-D52750E4E0B9Q40153913-0A31DF2C-F979-4076-813E-FC7296DF8628
P2860
Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeits
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Antimicrobial therapy of unexp ...... of Unexplained Fever, Arbeits
@en
type
label
Antimicrobial therapy of unexp ...... of Unexplained Fever, Arbeits
@en
prefLabel
Antimicrobial therapy of unexp ...... of Unexplained Fever, Arbeits
@en
P2093
P1433
P1476
Antimicrobial therapy of unexp ...... ft (DKG-German Cancer Society)
@en
P2093
Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
G Maschmeyer
Group Interventional Therapy o ...... ft (DKG-German Cancer Society)
H Ostermann
M R Nowrousian
P304
P356
10.1007/S00277-003-0764-4
P478
82 Suppl 2
P577
2003-09-09T00:00:00Z